Fullsizeoutput 664d
Fullsizeoutput 47f6


A novel vascular graft, based on our platform STAR biomaterial, to address the critical need for improved dialysis access in patients with kidney failure.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Seattle, WA, US
  • Currency USD
  • Founded March 2007
  • Employees 8
  • Incorporation Type C-corp
  • Website healionics.com

Company Summary

Healionics is addressing the critical need for improved means of dialysis access in patients with kidney failure. Our STARgraft vascular graft (artificial blood vessel) resists the problems of occlusion and infection suffered by current devices. We also have an exciting product pipeline based on our platform STAR® biomaterial, which has a unique ability to prevent both scarring & infection in many other implantable device applications.


  • 30 years working with early stage medical device companies in range of capacities, including entrepreneurial, venture investing, and executive roles. Co-founded several cos. early in career, including two with exits worth a combined $365M. Later led regional office for $400M VC firm, and served as CEO of one of its portfolio cos. from founding thru advanced clinicals. MBA from Stanford University, M.S. from MIT, B.S. from U.S. Naval Academy.